Title : PPARS, metabolic disease and atherosclerosis.

Pub. Date : 2001 Nov

PMID : 11712864






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PPAR-alpha activators (gemfibrozil) decrease the risk of coronary heart disease in patients with normal LDL-cholesterol and low HDL-cholesterol (VA-HIT) and they slow the progression of premature coronary atherosclerosis (BECAIT) (bezafibrate), particularly in patients with type 2 diabetes (DAIS) (fenofibrate). Gemfibrozil peroxisome proliferator activated receptor alpha Homo sapiens